ArticleFuture oncology (London, England)2016

Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemia.

Gail J Roboz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.